Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gore tests blood flow reversing embolic protection tech in carotid stent trial:

This article was originally published in Clinica

Executive Summary

WL Gore & Associates has begun in the US a study to test the safety and efficacy of its catheter-based system for preventing emboli from escaping to the brain during carotid artery stenting procedures. The Neuro Protection system is unique in that it operates on the principle of reversing the flow of blood at the treatment site, the company said, adding that the technique would provide doctors with the confidence that they have safely directed liberated emboli away from the brain. The study, called EMPiRE has already enrolled its first patients, all of whom have recovered from their procedure without incident, and have been discharged from hospital, said the Flagstaff, Arizona firm.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT052526

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel